Original Research Article
Clusters of Cognitive and Behavioral Disorders Clearly Distinguish Primary Progressive Aphasia from Frontal Lobe Dementia, and Alzheimer’s DiseaseMarra C.a · Quaranta D.a · Zinno M.a · Misciagna S.b · Bizzarro A.a · Masullo C.a · Daniele A.a · Gainotti G.a
aNeuropsychology Service of the Catholic University of Rome, Policlinico Gemelli, and bFondazione ‘Don Carlo Gnocchi’, Rome, Italy
Dr. Camillo Marra
Servizio di Neuropsicologia, Università Cattolica/Policlinico Gemelli
Largo A. Gemelli, 8
IT–00168 Roma (Italy)
Tel. +39 06 3015 4333, Fax +39 06 3550 1909, E-Mail email@example.com
Do you have an account?
Background/Aims: Frontal lobe dementia (FLD) and primary nonfluent progressive aphasia (PnPA) are two forms of frontotemporal lobe degeneration. The relationship between these conditions remains unclear. Our study aimed to better define the behavioral and cognitive clusters characterizing PnPA patients. Methods: We cognitively and behaviorally evaluated three groups of newly diagnosed patients affected by Alzheimer’s disease (AD, n = 20), FLD (n = 22) and PnPA (n = 10), in order to assess the cognitive-behavioral pattern of PnPA, compared to both FLD and AD. Results: We found, as expected, worse performances in episodic memory in AD, of both the verbal fluency and naming tasks in PnPA, while FLD mainly showed behavioral disorders associated with an unremarkable deficit in the executive tasks. PnPA was not characterized by any significant behavioral disorders. Factor analysis-extracted three main factors (‘mnesic’, ‘behavioral’ and ‘linguistic’) clearly correlated to each group. A discriminant analysis based on the extracted factors correctly classified 84.6% of all patients. Conclusion: The evidence of a characteristics cognitive profile, without any significant behavioral changes, highlights that PnPA is different from other forms of frontotemporal lobe degeneration regarding both the cognitive and behavioral patterns; thus, it should be considered independently in further studies.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.